Breaking News from Other Sources news and information

The orthopedic unit of Johnson & Johnson said that it was phasing out production of all-metal replacement hips, a move reflecting an industrywide trend to abandon the once widely used implants because of high early failure rates.
FULL STORY »

Physician assistants may soon have more opportunities to practice in Missouri. A bill headed to the Governor's desk would provide more flexibility in how and where they provide care.
FULL STORY »

Two doctors are set to ask a U.S. judge to block the Human Heartbeat Protection Act, an Arkansas law banning most abortions at the 12th week of pregnancy if a fetal heartbeat can be detected.
FULL STORY »

Nebraska lawmakers advanced a bill Thursday that would create a pilot program to offer behavioral health services to children through computer technology.
FULL STORY »

The Republican-controlled Arizona Senate passed a state budget that includes expansion of the state Medicaid program.
FULL STORY »

The Boston Public Health Commission has backed off its request for bombing victims' medical records, after three Boston police, fire and EMS unions accused the agency of trying to breach doctor-patient confidentiality.
FULL STORY »

Nurses at Marin General Hospital, Greenbrae, Calif., have asked administrators to put implementation of a new computerized physician order entry system on hold until glitches can be worked out and more training provided to nurses and doctors who use it.
FULL STORY »

On any given day inside Carmichael, Calif.-based Mercy San Juan Medical Center's neuro-intensive care unit, a 5-foot-6-inch-tall robot with a computer screen can be seen roaming the halls. The robot is equipped with videoconferencing capabilities so doctors can beam in when there is an emergency.
FULL STORY »

With a $2.1 million federal grant, Ohio will expand a database for background checks allowing healthcare companies to be immediately notified if workers have been convicted of a crime that would ban them from the job.
FULL STORY »

A heated takeover battle has erupted around generic-drug company Actavis as industry players seek to shore themselves up amid increasing competition and fewer new knock-off-drug opportunities.
FULL STORY »